Search Results - "Sledge GW"

Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.

Authors: Sparano JA Wang M Zhao F et al.

Source: JNCI: Journal of the National Cancer Institute. Mar2012, Vol. 104 Issue 5, p406-414. 9p.

An AI Approach to Differentiating Lung Squamous Cell Carcinoma From Metastases of Other Origins.

Authors: Evans MG Ribeiro JR Maney T et al.

Source: JAMA network open [JAMA Netw Open] 2026 Mar 02; Vol. 9 (3), pp. e260908. Date of Electronic Publication: 2026 Mar 02.

Publication Type: Journal Article

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Mechanisms of resistance to trastuzumab deruxtecan in breast cancer elucidated by multi-omic molecular profiling.

Authors: Sledge GW Xiu J Mahtani RL et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Dec 20; Vol. 12 (1), pp. 1. Date of Electronic Publication: 2025 Dec 20.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Long Road Home: The Continuing Journey of Metastatic Disease.

Authors: Sledge GW Jr; Caris Life Sciences, Palo Alto, CA.

Source: JCO oncology practice [JCO Oncol Pract] 2026 Jun 25, pp. OP2600483. Date of Electronic Publication: 2026 Jun 25.

Publication Type: Editorial

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

Spatially resolved single-cell landscape of tumor immunotypes reveals the central role of interferon signaling and plasmacytoid dendritic cells in triple-negative breast cancer.

Authors: Liu Y Carter JM Ma Y et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2026 Jun 03; Vol. 14 (6). Date of Electronic Publication: 2026 Jun 03.

Publication Type: Journal Article

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Development of indole derived non-orthosteric inhibitors for Proto-oncogene serine/threonine-protein kinase PIM-1.

Authors: Grau BW Tailor D Pandrala M et al.

Source: European journal of medicinal chemistry [Eur J Med Chem] 2026 May 29; Vol. 316, pp. 118931. Date of Electronic Publication: 2026 May 29.

Publication Type: Journal Article

Journal Info: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE

Loss of Flotillin-2 enhances trastuzumab emtansine internalization and cytotoxicity by relieving negative regulation of HER2 internalization in HER2-amplified cancers.

Authors: Wisniewski DJ Pritz RK Munch J et al.

Source: BioRxiv : the preprint server for biology [bioRxiv] 2026 May 19. Date of Electronic Publication: 2026 May 19.

Publication Type: Journal Article; Preprint

Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Broader gene representation by whole-exome sequencing improves accuracy of tumor mutational burden assessment for selection of pembrolizumab immunotherapy.

Authors: Radovich M Wacker J Solzak J et al.

Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 May 11; Vol. 75 (6). Date of Electronic Publication: 2026 May 11.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

Multi-Omic Landscape of Gastrointestinal Stromal Tumors in a Real-World Patient Cohort of 1,427 Cases.

Authors: Serrano C Elliott A Gómez-Peregrina D et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Apr 30. Date of Electronic Publication: 2026 Apr 30.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Payload Diversification Overcomes Resistance and Guides Sequential Antibody-Drug Conjugate Therapy in Breast Cancer.

Authors: Rampa DR Seo M Ogata N et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Apr 15; Vol. 32 (8), pp. 1454-1461.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Etirinotecan Pegol (NKTR-102) in Patients With Active Brain Metastases From Lung or Breast Cancer.

Authors: Nagpal S Nguyen KS Bertrand S et al.

Source: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2025 Sep; Vol. 8 (9), pp. e70330.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101747728 Publication Model: Print Cited Medium: Internet ISSN: 2573-8348 (Electronic) Linking ISSN: 25738348 NLM ISO Abbreviation: Cancer Rep (Hoboken) Subsets: MEDLINE

Predicting ROS1 and ALK fusions in NSCLC from H&E slides with a two-step vision transformer approach.

Authors: Amidi E Ramzanpour M Chen M et al.

Source: NPJ precision oncology [NPJ Precis Oncol] 2025 Jul 30; Vol. 9 (1), pp. 266. Date of Electronic Publication: 2025 Jul 30.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

A 20-feature radiomic signature of triple-negative breast cancer identifies patients at high risk of death.

Authors: Noor H Zheng Y Mantz AB et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Jul 26; Vol. 11 (1), pp. 79. Date of Electronic Publication: 2025 Jul 26.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Genomic landscape, immune microenvironment and survival in male versus female breast cancer.

Authors: Trapani D Deshmukh SK Samec T et al.

Source: ESMO open [ESMO Open] 2026 Mar; Vol. 11 (3), pp. 106059. Date of Electronic Publication: 2026 Mar 04.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Clinical Utility of Transcriptomic Signatures to Identify Androgen Receptor and Neuroendocrine Signaling in Prostate Cancer.

Authors: Chen YW Xiu J Poorman KA et al.

Source: JCO precision oncology [JCO Precis Oncol] 2026 Mar; Vol. 10, pp. e2500756. Date of Electronic Publication: 2026 Mar 05.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

EGFR amplification and PI3K pathway mutations identify a subset of breast cancers that synergistically respond to EGFR and PI3K inhibition.

Authors: Wisniewski DJ Voeller D Addissie YA et al.

Source: Oncogene [Oncogene] 2026 Jan; Vol. 45 (1), pp. 15-25. Date of Electronic Publication: 2025 Nov 25.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE

CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108.

Authors: Stearns V ONeill A Schneider BP et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Feb; Vol. 209 (3), pp. 595-602. Date of Electronic Publication: 2024 Oct 21.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in Nonsmall Cell Lung Cancer.

Authors: Watson AS Krause HB Elliott A et al.

Source: Clinical lung cancer [Clin Lung Cancer] 2024 Dec; Vol. 25 (8), pp. 712-722.e1. Date of Electronic Publication: 2024 Sep 12.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

Author Correction: Synergistic H&E and IHC image analysis by AI predicts cancer biomarkers and survival outcomes in colorectal and breast cancer.

Authors: Cheng Y Lama N Chen M et al.

Source: Communications medicine [Commun Med (Lond)] 2025 Oct 24; Vol. 5 (1), pp. 435. Date of Electronic Publication: 2025 Oct 24.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918250414506676 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-664X (Electronic) Linking ISSN: 2730664X NLM ISO Abbreviation: Commun Med (Lond) Subsets: PubMed not MEDLINE

A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105).

Authors: Mezzanotte-Sharpe J ONeill A Mayer IA et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Sep; Vol. 207 (2), pp. 275-282. Date of Electronic Publication: 2024 Jul 05.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE